Bph Energy Limited · ASX:BPH
Bph Energy — BioPharmica — Investor Presentation (July 2009)
19 slides from Bph Energy's investor presentation, Jul 1, 2009
Slide 1: BioPharmica Limited Company Overview
For personal use only BioPharmica Limited [ASX: BPH] Company Overview July 2009
Slide 2: BioPharmica Disclaimer
BioPharmica Disclaimer This document has been prepared by BioPharmica Limited to provide existing and prospective shareholders and other interested stakeholders in For personal use only BioPharmica Limited with broad information concerning its projects and business. Any statements, opinions or other
Slide 3: Executive Summary
Executive Summary BioPharmica Limited [ASX: BPH] is an Australian Securities Exchange listed company developing biomedical research and technologies within Australian For personal use only Universities and Hospital Institutes. BioPharmica provides early stage funding, project management and commerci
Slide 4: Strategic Position
For personal use only Strategic Position BioPharmica is an investor in early stage life sciences projects Angel IPO, ASX Investor and/or VC IPO USA Company University Company Start-Up Clinical Phase or Research Development Revenues Research Commercialisation Grants Grants
Slide 5: Corporate Structure
For personal use only Corporate Structure BioPharmica Limited ASX: BPH (SHAREHOLDERS #1,564) Chairman Non-Executive Director Non-Executive Director Non-Executive Director David Breeze Seng Yap Goh Hock Greg Gilbert Scientific Advisor Company Secretary Professor Peter Klinken Deborah Ambrosini
Slide 6: Project Structure
For personal use only Project Structure BioPharmica Limited Parent Company * Early Stage Funding * Management Diagnostic Array Molecular Discovery Anti-Mitotic Cancer Joint Venture Systems (DAS) Cortical Dynamics Systems Therapeutics (HLS5) Investee Investee (MDSystems) Investee Biomarker, Targets I
Slide 7: Novel Anti-Mitotic Cancer Therapeutics
Novel Anti-Mitotic Cancer Therapeutics Our Technology For personal use only Unregulated cell growth and evasion of cell death are two of the fundamental hallmarks of cancer. BioPharmica has recently identified new anti-cancer agents that inhibit rapid cell growth and promote cell death. In light of
Slide 8: Novel Anti-Mitotic Cancer Therapeutics: Data
Novel Anti-Mitotic Cancer Therapeutics Data For personal use only The exceptional tumour inhibitory activity of anti-mitotic drugs is due to their unique ability to inhibit cell proliferation and promote cell death (Figure 1). Our data supports this mechanism of action. Intellectual Property The com
Slide 9: Molecular Discovery Systems
Molecular Discovery Systems Molecular Discovery Systems (MDSystems) is a 100% owned subsidiary of For personal use only BioPharmica Limited. The main business is drug discovery and the validation of biomarkers for disease, therapy and diagnostics. MDSystems also provides screening services using the
Slide 10: Molecular Discovery Systems
Molecular Discovery Systems High content analysis utilises high-resolution fluorescence imaging and advanced image analysis to visualise cell based assays. It is a technique For personal use only used by pharmaceutical and biotech industries in their drug development process for mechanism of action
Slide 11: Tumour Suppressor Gene HLS5
For personal use only Tumour Suppressor Gene HLS5 BioPharmica’s tumour suppressor gene project was reported by Professor Klinken's team in 2004. In conjunction with BioPharmica the expert team at The West Australian Institute for Medical Research (WAIMR) led by Director Professor Peter Klinken are c
Slide 12: Tumour Suppressor Gene HLS5
Tumour Suppressor Gene HLS5 BioPharmica has developed an extensive patent portfolio and has exclusive For personal use only rights to the tumor suppressor gene HLS5 both as a potential therapeutic target and also underpinning its involvement in a variety of disease pathways. The patent portfolio of
Slide 13: Diagnostic Array Systems (DAS)
Diagnostic Array Systems (DAS) Technology For personal use only The BacTrak System is a diagnostic test for the detection of respiratory infections (e.g. diagnosis of pneumonia, Tuberculosis (TB) and Legionella disease). Our system identifies the cause of disease by testing for multiple bacteria in
Slide 14: Diagnostic Array Systems (DAS)
Diagnostic Array Systems (DAS) Conventional Method BacTrak Method For personal use only • Not automated • Most of the procedure automated • Requires 2-3 days or several weeks for some • Requires only 4-5 hours for all bacteria bacteria • Single test at a time • Multiple tests done simultaneously • U
Slide 15: Cortical Dynamics
Cortical Dynamics Technology • Brain activity monitor that measures EEG For personal use only • Algorithm based on physiology underlying the EEG signal Product • Brain Anaesthesia Response (BAR) Monitor • Other potential uses: Neurodiagnostics and drug monitoring. The market for depth of anaesthesia
Slide 16: Cortical Dynamics
Cortical Dynamics • The Cortical Dynamics BAR analysis is based on the physiological For personal use only mechanisms that generate brain electrical activity allowing the BAR Monitor to be quicker, far more sensitive and accurate than existing monitors. • The Cortical Dynamics team have completed tw
Slide 17: Competitive Advantages
For personal use only Competitive Advantages • BioPharmica partners with academic institutions on projects that have excellent scientific merit, strong intellectual property position and commercial potential. • Research is carried out by the acknowledged experts in the field while BioPharmica provid
Slide 18: Summary
Summary • Significant potential return for investors. For personal use only • Current license and commercial opportunities in three of its project portfolio. • Anti-cancer therapeutic and the BAR monitor both address product areas which have $1 billion US market size. • The DAS BacTrak product has g
Slide 19: For personal use only
For personal use only ABN 41 095 912 002 14 View Street North Perth Western Australia 6006 Australia Telephone: +61 8 9328 8366 Facsimile: +61 8 9328 8733 Email: admin@biopharmica.com.au Website: www.biopharmica.com.au